Parkland Memorial Hospital, Parkland Health and Hospital System, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
J Investig Med. 2012 Apr;60(4):671-5. doi: 10.2310/JIM.0b013e31824963f1.
The current therapy for patients hospitalized with ascites requires titration of oral diuretics and often needs several days. A faster method for predicting the response to a given dose of diuretic may allow this process to be completed more rapidly.
The objective of this study was to describe the short-term safety and efficacy of a diuretic infusion to predict net sodium excretion in patients with cirrhosis, ascites, and edema using a fractional excretion of sodium (FENa) of 1% or greater as the target.
We conducted a retrospective case series of patients admitted for management of ascites who received intravenous furosemide by continuous infusion in ascites management. Patients were stratified depending on whether they had edema or received an intravenous bolus of furosemide or a large-volume paracentesis. The primary outcome was the proportion of patients achieving a FENa of 1% or greater during the infusion. Secondary outcomes included development of electrolyte abnormalities or acute kidney injury during or immediately following the infusion and natriuresis on titrated oral furosemide.
Forty-seven patients meeting criteria were identified from 721 patients seen in consultation. Ten of the patients had edema and received neither bolus intravenous diuretic therapy nor therapeutic paracentesis; all 10 achieved a FENa of 1% or greater. One patient had transient hypokalemia. Of 37 patients who either had no edema or received additional treatment options, all but 6 patients achieved a FENa of 1% or greater. Transient complications in 31 patients with natriuresis included hyponatremia (n = 1), hypokalemia (n = 5), and acute kidney injury (n = 3). Twenty-four-hour urine sodium averaged more than 4 g/d on the titrated oral furosemide regimen in 19 patients completing the collection.
Use of a short continuous furosemide infusion can achieve a FENa of 1% or greater in patients with cirrhotic ascites and may be safe and efficacious for diuresis, meriting further study.
目前,住院腹水患者的治疗需要滴定口服利尿剂,通常需要数天时间。更快地预测给定剂量利尿剂反应的方法可能会使这一过程更快完成。
本研究旨在描述一种利尿剂输注方法的短期安全性和有效性,该方法通过使用钠排泄分数(FENa)≥1%来预测肝硬化、腹水和水肿患者的净钠排泄,作为目标。
我们对接受腹水管理中静脉呋塞米持续输注的住院腹水患者进行了回顾性病例系列研究。根据是否有水肿、是否接受静脉呋塞米推注或大容量腹腔穿刺术,对患者进行分层。主要结局是输注过程中达到 FENa≥1%的患者比例。次要结局包括输注期间或输注后立即出现电解质异常或急性肾损伤以及滴定口服呋塞米的利钠作用。
从 721 例会诊患者中确定了 47 例符合标准的患者。10 例患者有水肿,未接受静脉利尿剂推注治疗或治疗性腹腔穿刺术;所有 10 例患者的 FENa 均达到 1%或更高。1 例患者出现短暂性低钾血症。在 37 例无水肿或接受其他治疗选择的患者中,除 6 例外,所有患者的 FENa 均达到 1%或更高。31 例有利钠作用的患者中出现短暂并发症,包括低钠血症(n=1)、低钾血症(n=5)和急性肾损伤(n=3)。在完成 24 小时尿液收集的 19 例患者中,滴定口服呋塞米方案的 24 小时尿钠平均超过 4 g/d。
短时间持续输注呋塞米可使肝硬化腹水患者的 FENa 达到 1%或更高,可能安全有效,值得进一步研究。